1. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase
- Author
-
Watson, K. A., Chrysina, Evangelia D., Tsitsanou, K. E., Zographos, Spyros E., Archontis, Georgios Z., Fleet, G. W. J., Oikonomakos, Nikos G., Zographos, Spyros E. [0000-0001-8455-2352], Chrysina, Evangelia D. [0000-0001-8147-9030], and Archontis, Georgios Z. [0000-0002-7750-8641]
- Subjects
Models, Molecular ,Glycogenolysis ,Molecular Conformation ,Crystallography, X-Ray ,Biochemistry ,chemistry.chemical_compound ,Structural Biology ,enzyme kinetics ,binding affinity ,Spirohydantoins ,Enzyme Inhibitors ,enzyme inhibition ,Inhibition ,Glucosamine ,biology ,Glycogen ,Chemistry ,Hydrogen bond ,Glycogen Phosphorylase ,article ,Glycogen phosphorylase ,Conformational entropy ,Ligand (biochemistry) ,unclassified drug ,glycogen phosphorylase inhibitor ,priority journal ,Enzyme inhibitor ,crystal structure ,X ray diffraction ,glucopyranosylamine derivative ,Stereochemistry ,ligand binding ,enzyme inhibitor ,glycogen metabolism ,Drug design ,animal tissue ,Structure-Activity Relationship ,thermodynamics ,spirohydantoin derivative ,Animalia ,Enzyme kinetics ,Molecular Biology ,X-ray crystallography ,hydrogen bond ,nonhuman ,catalysis ,Hydantoins ,drug targeting ,X ray crystallography ,Kinetics ,Crystallography ,Glucose ,molecular interaction ,biology.protein - Abstract
Glycogen phosphorylase (GP) is currently exploited as a target for inhibition of hepatic glycogenolysis under high glucose conditions. Spirohydantoin of glucopyranose and N-acetyl-β-D-glucopyranosylamine have been identified as the most potent inhibitors of GP that bind at the catalytic site. Four spirohydantoin and three β-D-glucopyranosylamine analogs have been designed, synthesized and tested for inhibition of GP in kinetic experiments. Depending on the functional group introduced, the Ki values varied from 16.5 μM to 1200 μM. In order to rationalize the kinetic results, we determined the crystal structures of the analogs in complex with GP. All the inhibitors bound at the catalytic site of the enzyme, by making direct and water-mediated hydrogen bonds with the protein and by inducing minor movements of the side chains of Asp283 and Asn284, of the 280s loop that blocks access of the substrate glycogen to the catalytic site, and changes in the water structure in the vicinity of the site. The differences observed in the K i values of the analogs can be interpreted in terms of variations in hydrogen bonding and van der Waals interactions, desolvation effects, ligand conformational entropy, and displacement of water molecules on ligand binding to the catalytic site. © 2005 Wiley-Liss, Inc. 61 4 966 983 Cited By :21
- Published
- 2016